Business & Economy · 2 views
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted.
Source NYT Story Brief Updated 54m ago
Business & Economy 
Story intelligence Beta
Confidence Limited Single-outlet story
Views 2 Community interest
Read time 1 min ~18 words
Story Brief
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Read full article on The New York TimesAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- Gen Z's new anti-tech rebellion: making eye contact and listening to each otherContinue reading
- Our 4-year-old son has $100,000 in his 529 account. Should we buy him stocks instead?Continue reading
- Can We Do Anything About Tick-Borne Diseases Like Alpha-Gal Syndrome?Continue reading
- Humanoid robots' 'ChatGPT moment' could be 10 years away, Unitree founder saysContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow